Support Program

BEOVU Your Way Program logo

Welcome to the BEOVU
Your Way program

BEOVU Your Way Program logo

BEOVU Your Way™ is a program designed to support people living with wet age-related macular degeneration (wet AMD) and their loved ones. The program provides personalized 1-on-1 support throughout the treatment journey with access to a dedicated Care Champion.

Care Champion icon

Who are Care Champions?

Care Champions are specialists in the BEOVU Your Way program committed to understanding your needs and preferences while you are on BEOVU treatment.

When you become a member of BEOVU Your Way, you will be matched with a dedicated Care Champion, who will be your point of contact for personalized support.

Your Care Champion can help in several ways:

BEOVU information icon

Answer questions you may have about BEOVU therapy

Car icon

Provide you with transportation support options and appointment reminders

Map pin icon

Connect you to wet AMD support groups and resources for changing vision

Hand and $ icon

Assist you in understanding your insurance coverage and financial support options, if needed

Support also available in Spanish.

BEOVU Your Way is a trademark of Novartis AG.

BEOVU Your Way is a support program and is not intended to take the place of the care provided by your doctor and their office staff. BEOVU Your Way, including the Care Champions, does not provide medical treatment or medical advice.

How do I enroll in
BEOVU Your Way?

Click here to sign up for support

Or call 1-888-612-3688 1-888-612-3688

Available Monday through Friday,
8 AM to 8 PM ET

Text
Size

Contrast

Back to Top Back to Top

Expand

Close

INDICATION

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD).

IMPORTANT SAFETY INFORMATION

You should not use BEOVU if you have an infection in or around the eye, eye inflammation, or if you are allergic to brolucizumab or any of the ingredients in BEOVU.

BEOVU is a prescription medicine given by injection into the eye. Injections in the eye, including BEOVU, may cause an infection of the eye or retinal detachment (separation of retina from the back of the eye). It is important to contact your doctor right away if your eye becomes red, sensitive to light, painful, or you develop any change in your vision.

Increased eye pressure has been seen within 30 minutes of an eye injection, including BEOVU. Sustained increases in eye pressure also have been reported. Your doctor should monitor for this when you receive a BEOVU injection.

There is a potential risk of stroke, heart attack, or blood clots in patients receiving eye injections of vascular endothelial growth factor (VEGF) inhibitor drugs, including BEOVU. Sudden vision loss due to blockage of the blood vessels in the back of the eye and inflammation of blood vessels in the back of the eye have been reported.

The most common side effects reported in patients receiving BEOVU were reduced clarity in vision, cataract, broken blood vessels in the eye, and vitreous floaters (moving spots in the field of vision).

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.

Please see full Prescribing Information.

INDICATION

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD).